Author: Himanshu Patni
21 November 2022
External ventricular drain is a temporary system that allows the drainage of cerebral spinal fluid from the ventricles to an external closed system. It is considered one of the life-saving and most common procedures in the neurologic intensive care unit. The external ventricular drain market is expected to witness in the upcoming years owing to the growing geriatric population coupled with the rising burden of various neurological diseases across the globe. For instance, According to the WHO, neurological disorders ranging from epilepsy to Alzheimer’s disease, from stroke to headache, affect up to 1 billion people worldwide. Also, an estimated 6.8 million people die every year as a result of neurological disorders.
The External Ventricular Drain Market is expected to grow at a steady rate of around 7% during the forecast period. Furthermore, rapid technological advancement, rising research and development activities and an increasing need for minimally invasive or non-invasive neurosurgeries to reduce trauma and improve patient outcomes are also some of the factors contributing to the growth of the external ventricular drain market across the globe.
Based on the application, the external ventricular drain market is segmented into traumatic brain injury, intracranial haemorrhage, hydrocephalus, and others. The traumatic brain injury segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to an increase in the number of road accidents leading to rise in the prevalence of traumatic brain injuries. However, the hydrocephalus segment is also expected to grow considerably during the forecast period as it affects a large number of people globally.
For a detailed analysis of the Global External Ventricular Drain Market browse through – https://univdatos.com/report/external-ventricular-drain-market/
Based on end-user, the market is fragmented into hospitals, ambulatory surgical centers and others. The hospitals segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period. This can be due to an increased preference for patients to get treatment in hospitals owing to the presence of skilled healthcare professionals, availability of technologically advanced equipment, and a well-established infrastructure.
For a better understanding of the market adoption of the external ventricular drains, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, high incidences of traumatic brain injuries and a growing prevalence of neurovascular disorders in the region. For instance, as per the CDC, stroke is the fifth leading cause of death and over 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies are also contributing towards the growth of the market for the external ventricular drain in the region.
Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=27458
Some of the major players operating in the market include Medtronic Plc, Spiegelberg Gmbh & Co. Kg, Moller Medical Gmbh, Braun Melsungen Ag, Integra Life Sciences Corporation, Pfizer Inc., Cadila Pharmaceuticals, Sophysa, Fuji Systems, Geistlich Pharma Inc.
Global External Ventricular Drain Market Segmentation
Market Insight, by Application
Market Insight, by End-User
Market Insight, by Region
Top Company Profiles
Get a call back
